FibroGen (FGEN) Misses Q1 EPS by 6c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $36.16 million versus the consensus estimate of $31.67 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Meritage Hospitality posts Q2 loss amid restructuring charges
• Cantor Fitzgerald Reiterates Overweight Rating on DBV Technologies S.A (DBVT)